(NP (NP (NN Regulation)) (PP (IN of) (NP (NN c-jun) (NN expression))) (PP-TMP (IN during) (NP (NP (NN induction)) (PP (IN of) (NP (JJ monocytic) (NN differentiation))))) (PP (IN by) (NP (JJ okadaic) (NN acid))) (. .))
(S (NP-SBJ (DT The) (JJ present) (NN work)) (VP (VBZ has) (VP (VBN examined) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ okadaic) (NN acid)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN type) (NP-COOD (NP (CD 1)) (CC and) (NP (NN 2A))) (NN protein) (NNS phosphatases)))) (, ,))) (PP (IN on) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN c-jun) (NN expression))) (PP-TMP (IN during) (NP (NP (JJ monocytic) (NN differentiation)) (PP (IN of) (NP (NN U-937) (NN leukemia) (NNS cells)))))))))) (. .))
(S (NP-SBJ (DT The) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ-27 (JJ okadaic) (NN acid) (NN treatment)) (VP (VBZ is) (VP (VBN associated) (NP (-NONE- *-27)) (PP (IN with) (NP (NP (NN induction)) (PP (IN of) (NP (NP (DT a) (VBN differentiated) (NN monocyte) (NN phenotype)) (VP (VBN characterized) (NP (-NONE- *)) (PP (IN by) (: :) (NP-LGS-COOD (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NN growth) (NN arrest)) (: ;) (NP (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NNS increases)) (PP (IN in) (NP (NN Mac-1) (NN cell) (NN surface) (NN antigen) (NN expression)))) (: ;) (NP (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (NP (NN down-regulation)) (PP (IN of) (NP (NN c-myc) (NNS transcripts)))) (: ;) (CC and) (NP (LST (-LRB- -LRB-) (LS d) (-RRB- -RRB-)) (NP (NN induction)) (PP (IN of) (NP (NN tumor) (NN necrosis) (NN factor) (NN gene) (NN expression)))))))))))))))) (. .))
(S (NP-SBJ-28 (NP (DT This) (NN induction)) (PP (IN of) (NP (JJ monocytic) (NN differentiation)))) (VP (VBD was) (VP (VBN associated) (NP (-NONE- *-28)) (PP (IN with) (NP (NP (JJ transient) (NNS increases)) (PP (IN in) (NP (NP (NN c-jun) (NN mRNA) (NNS levels)) (, ,) (SBAR (WHNP-29 (WDT which)) (S (NP-SBJ (-NONE- *T*-29)) (VP (VBD were) (ADJP-PRD (JJ maximal)) (PP-TMP (IN at) (NP (CD 6) (NN h)))))))))))) (. .))
(S (NP-SBJ-30 (JJ Similar) (NNS effects)) (VP (VBD were) (VP (VBN obtained) (NP (-NONE- *-30)) (PP (IN for) (NP (DT the) (NN c-fos) (NN gene))))) (. .))
(S (NP-SBJ (JJ Run-on) (NN analysis)) (VP (VBD demonstrated) (UCP-COOD (NP (NP (JJ detectable) (NNS levels)) (PP (IN of) (NP (NN c-jun) (NN transcription))) (PP (IN in) (NP (NN U-937) (NNS cells)))) (CC and) (SBAR (IN that) (S (NP-SBJ-31 (DT this) (NN rate)) (VP (VBZ is) (VP (VBN increased) (NP (-NONE- *-31)) (ADVP (RB approximately) (RB 40-fold)) (PP-TMP (VBG following) (NP (JJ okadaic) (NN acid) (NN exposure))))))))) (. .))
(S-COOD (S (NP-SBJ-32 (NN c-jun) (NN mRNA) (NNS levels)) (VP (VBD were) (VP (VBN superinduced) (NP (-NONE- *-32)) (PP (IN in) (NP (NP (NNS cells)) (VP (VBN treated) (NP (-NONE- *)) (PP (IN with) (NP-COOD (CC both) (NP (JJ okadaic) (NN acid)) (CC and) (NP (NN cycloheximide)))))))))) (, ,) (IN whereas) (S (NP-SBJ (NP (NN inhibition)) (PP (IN of) (NP (NN protein) (NN synthesis)))) (VP (VBD had) (NP (NP (JJ little) (PRN (, ,) (SBAR (IN if) (FRAG (ADJP (DT any)))) (, ,)) (NN effect)) (PP (IN on) (NP (ADJP (JJ okadaic) (JJ acid-induced)) (NN c-jun) (NN transcription)))))) (. .))
(S (NP-SBJ (NP (DT The) (NN half-life)) (PP (IN of) (NP (NN c-jun) (NN mRNA)))) (VP (VBD was) (ADJP-PRD (ADJP (JJ similar)) (PRN (-LRB- -LRB-) (NP (QP (CD 45-50)) (NN min)) (-RRB- -RRB-))) (PP (IN in) (NP (ADJP-COOD (CC both) (ADJP (JJ untreated)) (CC and) (ADJP (JJ okadaic) (JJ acid-induced))) (NNS cells)))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-33 (NP (NN treatment)) (PP (IN with) (NP-COOD (DT both) (NP (JJ okadaic) (NN acid)) (CC and) (NP (NN cycloheximide))))) (VP (VBD was) (VP (VBN associated) (NP (-NONE- *-33)) (PP (IN with) (NP (NP (NP (NN stabilization)) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN t) (CD (2 1))) (VP (JJ =) (NP (CD 90) (NN min)))) (-RRB- -RRB-))) (PP (IN of) (NP (NN c-jun) (NNS transcripts))))))) (. .))
(S (S-ADV (NP-SBJ-34 (-NONE- *)) (VP (VBN Taken) (NP (-NONE- *-34)) (ADVP (RB together)))) (, ,) (NP-SBJ (DT these) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ-35 (NP (DT the) (NN induction)) (PP (IN of) (NP (NN c-jun) (NN transcription))) (PP (IN by) (NP (JJ okadaic) (NN acid)))) (VP (VBZ is) (VP (VBN controlled) (NP (-NONE- *-35)) (ADVP (RB primarily)) (PP (IN by) (NP-LGS (DT a) (JJ transcriptional) (NN mechanism)))))))) (. .))
(S (SBAR-ADV (IN Since) (S (NP-SBJ (JJ previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ-36 (DT the) (NN c-jun) (NN gene)) (VP (VBZ is) (VP (VBN autoinduced) (NP (-NONE- *-36)) (PP (IN by) (NP-LGS (NN (AP-1 Jun)))))))))))) (, ,) (NP-SBJ (PRP we)) (ADVP (RB also)) (VP (VBD studied) (NP (NP (NN transcription)) (PP (IN of) (NP (NN c-jun) (NN promoter) (PRN (-LRB- -LRB-) (NP (NNS positions) (NP-COOD (NP (CD (+170 -132))))) (-RRB- -RRB-)) (JJ -reporter) (NN gene) (NNS constructs))) (PP (PP-COOD (PP (IN with) (NP (-NONE- *RNR*-37))) (CC and) (PP (IN without) (NP (-NONE- *RNR*-37)))) (NP-37 (DT a) (VBN mutated) (NN AP-1) (NN element))))) (. .))
(S (-LRB- -LRB-) (NP-SBJ-101 (NN ABSTRACT)) (VP (VBN TRUNCATED) (NP (-NONE- *-101)) (PP (IN AT) (NP (CD 250) (NNS WORDS)))) (-RRB- -RRB-))
